Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran in Mechanical Heart Valve Patients (RE-ALIGN Extension)
NCT01505881Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of dabigatran, sponsored by Boehringer Ingelheim. Started Dec 2011; status: terminated.
02
Drugs
dabigatran
Beyond the preview
Go deeper on NCT01505881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505881.